NASDAQ$ALHC

Alignment Healthcare Inc · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

Reported solid performance driven by strategic investments in people and technology.

Alignment Healthcare reported a solid performance in Q3 2022, driven by strategic investments in people and technology, with their proprietary data platform AVA® playing a key role.

  • Alignment Healthcare's operating model demonstrates repeatability and scalability.
  • Strategic investments in people and technology are delivering durable financial results.
  • Proprietary data platform AVA® drives value and innovation.
  • Approximately 95% of members are in plans rated 4 stars or greater.

Headline financials

Total Revenue

$360M

Previous: $293M+22.8%
EPS (adj)

-$0.21

Previous: -$0.26+19.2%
Free Cash Flow

-$40.2M

Previous: -$45.8M+12.2%
Net Income

-$40.2M

Previous: -$45.8M+12.2%
Operating Income

-$33.4M

Previous: -$41.5M+19.4%
Gross Profit

$360M

Previous: $293M+22.8%
Cash & Equivalents

$567M

Previous: $500M+13.4%
Total Assets

$778M

Previous: $657M+18.4%
Stock-Based Comp

$18.7M

No prior period

Revenue & EPS history

Alignment Healthcare · Revenue · Quarterly

$360M

Q3 2022+22.8%vs Q3 2021
Beat estimate in 15 of 15 quarters(100%)
ActualEstimate

Revenue by segment

Alignment Healthcare · $265M total across 2 segments · Q1 2021

  • Earned premiums
    $265M+18.0%
  • Other revenue
    $82K

Forward guidance

The company provided financial outlook for the fourth quarter ending December 31, 2022, and year ending December 31, 2022.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

+1.8%

Avg return

Earnings day

+1.8%

Avg return

5 days after

+2.6%

Avg return

30 days after

57%

12 / 21 earnings

Positive

+27.0%

Q1 2024

Best reaction

-16.4%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.8%-15.7%-29.5%
Q4 2025-5.8%-7.5%-18.6%
Q3 2025-1.9%-0.4%+12.2%
Q1 2025-7.7%-7.5%-8.3%
Q4 2024+16.5%+17.4%+35.9%
Q3 2024+1.6%+12.2%+11.2%
Q2 2024+2.3%+4.9%+3.1%
Q1 2024+27.0%+31.6%+51.0%
Q4 2023-8.9%-9.2%-20.1%
Q3 2023-9.6%-7.2%+10.5%
Q2 2023+7.5%+10.5%-4.2%
Q1 2023+3.5%+11.3%-5.1%
Q4 2022-16.4%-20.9%-35.2%
Q3 2022-3.1%-3.3%-2.7%
Q2 2022+10.4%+4.3%-8.7%
Q1 2022-7.0%-18.8%+6.8%
Q4 2021+10.7%+8.0%+39.7%
Q3 2021+10.6%+6.1%-26.7%
Q2 2021-8.5%-4.8%-11.2%
Q1 2021+6.8%+13.3%+27.6%
Q4 2020+6.8%+13.3%+27.6%
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro